A New Tool for Helping Labs Improve Diversity in Clinical Trials
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
Open Content
Subscribe today for access to
Articles and Reports
G2 Intelligence Has Some Exciting News to Share!
G2 Intelligence to change subscription model to better serve the laboratory industry with more analysis and insight
Is a Newly Proposed Rule Meant to Stop Healthcare Consolidation?
The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.
Nationwide Takedown Headlines Busy Enforcement Week
Last week saw a takedown of $1.2B worth of alleged fraud schemes involving labs, genetic testing, and telemedicine.
Regular Screening Finds Pancreatic Cancer at Earliest Stage
A recent study shows that the disease was detected sooner in high-risk individuals who underwent screening than those who did not.
Lab Companies Launch New Tests for Monkeypox
Centers for Disease Control and Prevention spearheads US effort to quickly increase lab testing capacity and access.
Prior Authorization and Benefits Verification Automation for Diagnostic Labs
In this Q&A, Tyler Wince of Myndshft discusses the key issues labs face when it comes to benefits and prior authorization, and how technology can help.
OIG Warns Providers to Steer Clear of Telehealth Scams
First Special Fraud Alert in nearly two years cites six red flags of suspect arrangements with telehealth companies.
Mitigating Biotin Interference in Lab Tests
Biotin interference can lead to erroneous lab results in certain IVDs, including some troponin tests.
Diagnostic Lab to Pay Nearly $10 Million to Settle FCA Allegations
BioReference Health LLC and its parent company have agreed to pay $9.85 million to resolve alleged violations of the False Claims Act.
NCCN Recommends Molecular Testing for Pediatric Cancer Treatment
The new guidelines will likely prove highly influential with oncologists and payors.
CDC, Major Laboratory Companies Launch New Tests for Monkeypox
As the outbreak continues to grow in countries that have not historically seen monkeypox cases, testing companies are stepping up.
Lesion Samples Are Best When It Comes to Monkeypox Testing
Recent FDA Safety Communication warns of the potential of false results from other sample types when testing for the monkeypox virus.
